All News

Zavegepant is the first calcitonin gene-related peptide receptor for migraines in development as an intranasal formulation studied in a phase 3 trial.

Phase 3 trial results indicate efficacy against respiratory syncytial virus-lower respiratory tract disease in individuals aged 60 years and older.

Data show continued objective response rate, overall survival, and progression-free survival benefits of nivolumab plus cabozantinib in the treatment of advanced renal cell carcinoma.

The COVID-19 and flu test is a single-use at-home test kit that uses self-collected nasal swab samples and provides results in approximately 30 minutes.

Two members of a clinical-stage authoring group discuss education programs and the alternative career path of medical writing, which can offer hybrid/virtual work-life balance opportunities.

Evaluating tasks, such as appropriate site of care and plan benefits, frees up time for pharmacists.

Virologic suppression was similar between the long-acting and once-daily treatments for HIV, but participants were more satisfied with the former.

Lenacapavir, combined with broadly neutralizing HIV antibodies, found effective at viral suppression in patients with HIV.

High-risk areas for disease progression include genitalia and the scalp.

Farah Towfic, PharmD, MBA, RPh, director, CEO Operations, US Pharmacopeia, discusses some of the primary topics impacting pharmacists’ delivery of care and quality this year.

Extended infusion piperacillin/tazobactam was associated with lower odds of 14-day mortality compared to standard infusion piperacillin/tazobactam.

Elranatamab is an investigational B-cell maturation antigen CD3-targeted bispecific antibody that may become the next standard of care for multiple myeloma, according to researchers.

An expert shares information on risk factors and controversies around testing.

Ideally, older patients receive vaccinations by October, but disease activity often peaks in February or March.

Results of the ACTIV-6 study showed that high dose ivermectin use did not demonstrate a clinical benefit for mild to moderate COVID-19.

Hospitals, health systems, and the supply chain are all negatively impacted by drug shortages and are each affected by the decisions of the others.

Products range from Parkinson disease treatment to medication for epilepsy.

Cognitive performance was higher if a person maintained physical activity throughout their lifetime.

Increasing interventions for affordable housing and food security could contribute to reduced rates of heart disease in lower income communities.

Pharmacy technicians and pharmacy technician leadership from UPMC Presbyterian discuss how they became pharmacy technicians in health-system pharmacies.

If approved, the vaccine would be the first immunization for use in pregnant individuals to help protect against the complications of respiratory syncytial virus in infants from birth through 6 months.

Including the ThinPrep Pap Test improves access to the benefits of the human papillomavirus (HPV) assay, which is the only FDA-approved assay that tests for an extended set of HPV types individually.

Substance use disorder is a significant social, economic, and public health crisis, with far too few individuals receiving the treatment they need, particularly among communities of color.

Understanding the complicated web of insurers, discounts from government and commercial plans, and payer access is extremely complicated.

In a subgroup analysis, patients with COVID-19 who received conventional oxygen support also benefitted, having 20 fewer deaths per 1000 patients when given remdesivir.

Products include medications for depressive disorder and migraines.

Autoimmune diseases are often chronic conditions that can evolve, so minimizing damage and progression is typically the mainstay of treatment.

Pharmacologic approaches can reduce the risk of chronic GVHD.